Ovarian cancer
This treatment modality has been in practice since early 90s and has several random clinical trials in lung cancer, gastric cancer, Ovarian cancer and Liver cancer. which has been published with significant disease free survival rates. One of the largest studies in 1400 patients. has proven that the cell based immunotherapy when combined with conventional treatment the efficacy improves by 20–30%. A recent finding published about a relapsed stage IV ovarian cancer treated successfully with this methodology has found its place in the Global medical discovery.